Company news
Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A (SSE:603139) news
Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A news releases on 6ix. Latest, Nov 25, 2025: Announcement on Applying for Arbitration Regarding Performance…
Press releases — page 2
Announcement on Applying for Arbitration Regarding Performance Compensation Matters and Accumulated Litigation
November 24, 2025
Announcement on Increasing the Estimated Amount for Daily Related Party Transactions in 2025
November 20, 2025
Announcement on Resolutions of the 3rd General Meeting in 2025
November 14, 2025
Announcement on Applying for Arbitration Regarding Performance Compensation Matters
November 13, 2025
Announcement on Wholly-owned Subsidiary Completing Industrial and Commercial Change Registration
November 5, 2025
Announcement on Change of Drug Production License
November 3, 2025
Notice on Convening the 3rd Extraordinary General Meeting in 2025
October 29, 2025
Announcement on Progress in Lawsuit and Receipt of Notice of Withdrawal of Lawsuit
October 27, 2025
Announcement on Completing Change of Legal Representative and Renewing Business License
October 23, 2025
Announcement on Implementing Change of the Company's Stock Name
September 23, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 18, 2025
Announcement on Proposed Change of the Company's Stock Abbreviation
September 16, 2025
Announcement on Pledge of Partial Equities by Shareholders Holding More Than 5% of Shares
September 10, 2025
Announcement on Change of Company Email Address
September 9, 2025
Announcement on Completion of Control Change
September 4, 2025
2025 Semi-annual Report
August 26, 2025
Announcement on Renewal of Drug Manufacturing License
August 25, 2025
Announcement on Canceling the Board of Supervisors and Amending the Articles of Association and Amending and Formulating Related Systems
August 19, 2025
Announcement on Changes in the Company Name and Main Operating Location of Shareholders with Over 5% Shares
August 14, 2025